Sword Group
Sword Group: Availability of the 2024 Financial Report
Sword Group: Availability of the 2024 Financial Report
According to the current regulations, Sword Group announces that its 2024 Financial Report has been made available to the public.
It was sent to the Commission de Surveillance du Secteur Financier (CSSF) and was also filed with the Luxembourg Stock Exchange.
It can be viewed and downloaded on the website of the company:
Dividend
€2.0 gross per shre
Ex-date: April 30, 2025
Payment: May 2, 2025
Pending approval at the Annual General Meeting on April 28.
Calendar
24/04/25 | 2025 First Quarter Revenue
24/07/25 | 2025 Second Quarter Revenue
About Sword Group
Sword has 3,200+ IT/Digital specialists active in 50+ countries to accompany you in the growth of your organisation in the digital age.
As a leader in technological and digital transformation, Sword has a solid reputation in complex IT & business project management.
Sword optimises your processes and enhances your data.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novartis Pharma AG3.4.2025 02:13:00 CEST | Press release
Novartis receives FDA accelerated approval for Vanrafia® (atrasentan), the first and only selective endothelin A receptor antagonist for proteinuria reduction in primary IgA nephropathy (IgAN)
CRUSHON AI CORP3.4.2025 02:05:57 CEST | Press release
Crushon AI Adds Target Play for Spicy AI and NSFW Character Chats
Appian Capital Advisory2.4.2025 22:34:00 CEST | Press release
Appian completes sale of MVV to Baiyin Nonferrous for US$420 million
Nokia Oyj2.4.2025 21:45:00 CEST | Press release
Nokia completes the share buyback program launched in November 2024
Nokia Oyj2.4.2025 21:30:00 CEST | Press release
Nokia Corporation: Repurchase of own shares on 02.04.2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom